Name | Bethesda Of Beresford |
---|---|
Location | 606 W Cedar, Beresford, South Dakota |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 58 |
Occupancy Rate | 64.48% |
Medicare ID (CCN) | 435080 |
Legal Business Name | Bethesda Of Beresford |
Ownership Type | Non Profit - Church Related |
NPI Number | 1649264979 |
Organization Name | BETHESDA OF BERESFORD |
Address | 606 W Cedar St, Beresford, SD 57004 |
Phone Number | 605-763-2050 |
News Archive
The partners in a new publicly-funded European research project today announced details of the multinational/multidisciplinary program: 'CSI: Central Nervous System Imaging.' This three-year ENIAC project aims to achieve substantial advances in state-of-the-art medical 3D-imaging platforms by focusing on the diagnosis and therapy of serious diseases of the central nervous system and brain.
Fabre-Kramer Pharmaceuticals Inc. (FKP) and GlaxoSmithKline announced today that the U.S. Food and Drug Administration (FDA) has issued a not approvable letter for the new drug application for gepirone extended- release (ER) tablets, submitted for the treatment of adults with major depressive disorder.
John D. Groopman, Ph.D., has been selected to receive the 2010 American Association for Cancer Research-Prevent Cancer Foundation Award for Excellence in Cancer Prevention Research
A healthy ear is much better at detecting and transmitting sound than even the most advanced hearing aid. But now researchers reporting in the August 20 issue of the Biophysical Journal, a Cell Press publication, have uncovered new insights into how the ear - in particular, the cochlea - processes and amplifies sound.
Beckman Coulter returns analytical ultracentrifugation to the center of protein research and macromolecule characterization with the next-generation Optima AUC.
› Verified 7 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
The partners in a new publicly-funded European research project today announced details of the multinational/multidisciplinary program: 'CSI: Central Nervous System Imaging.' This three-year ENIAC project aims to achieve substantial advances in state-of-the-art medical 3D-imaging platforms by focusing on the diagnosis and therapy of serious diseases of the central nervous system and brain.
Fabre-Kramer Pharmaceuticals Inc. (FKP) and GlaxoSmithKline announced today that the U.S. Food and Drug Administration (FDA) has issued a not approvable letter for the new drug application for gepirone extended- release (ER) tablets, submitted for the treatment of adults with major depressive disorder.
John D. Groopman, Ph.D., has been selected to receive the 2010 American Association for Cancer Research-Prevent Cancer Foundation Award for Excellence in Cancer Prevention Research
A healthy ear is much better at detecting and transmitting sound than even the most advanced hearing aid. But now researchers reporting in the August 20 issue of the Biophysical Journal, a Cell Press publication, have uncovered new insights into how the ear - in particular, the cochlea - processes and amplifies sound.
Beckman Coulter returns analytical ultracentrifugation to the center of protein research and macromolecule characterization with the next-generation Optima AUC.
› Verified 7 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 0 |
Total Amount of Fines in Dollars | $0 |
Number of Payment Denials | 0 |
Total Number of Penalties | 0 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 10.67 | 14.46 |
Percentage of long-stay residents who lose too much weight | 5.37 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 40.85 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 2.71 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 2.98 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 9.04 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 10.73 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 98.31 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 5.71 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 56 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 3.7 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 25.46 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 11.46 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 0.88 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 100 | 95.98 |
Percentage of short-stay residents who made improvements in function | 48.13 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 96.67 | 82.93 |
News Archive
The partners in a new publicly-funded European research project today announced details of the multinational/multidisciplinary program: 'CSI: Central Nervous System Imaging.' This three-year ENIAC project aims to achieve substantial advances in state-of-the-art medical 3D-imaging platforms by focusing on the diagnosis and therapy of serious diseases of the central nervous system and brain.
Fabre-Kramer Pharmaceuticals Inc. (FKP) and GlaxoSmithKline announced today that the U.S. Food and Drug Administration (FDA) has issued a not approvable letter for the new drug application for gepirone extended- release (ER) tablets, submitted for the treatment of adults with major depressive disorder.
John D. Groopman, Ph.D., has been selected to receive the 2010 American Association for Cancer Research-Prevent Cancer Foundation Award for Excellence in Cancer Prevention Research
A healthy ear is much better at detecting and transmitting sound than even the most advanced hearing aid. But now researchers reporting in the August 20 issue of the Biophysical Journal, a Cell Press publication, have uncovered new insights into how the ear - in particular, the cochlea - processes and amplifies sound.
Beckman Coulter returns analytical ultracentrifugation to the center of protein research and macromolecule characterization with the next-generation Optima AUC.
› Verified 7 days ago